Skip to main content

Alleviate Labs

Clearer context for care.

We’re developing Bonsai, a handheld precision liquid dosing device designed for single-use oral solution pods and guided by a clinician’s plan.

Bonsai is pre-production. The patient app and Care Portal demos use fictional example data, not working hardware.

Plan → Bonsai → app → Care PortalFor patients, caregivers, care teams, and researchers
Bonsai device film frame showing the lit display and charging hardware
Pre-production product film excerpt

Built around people

Who is it for?

Explore the software demo from a patient, care-team, or research perspective.

Access depends on a current care relationship, not a job title alone.

Selected audience · 01

Plan → session record

Set a plan and review uploaded records.

The demo lets clinicians set session limits and review feedback from linked patients.

External research · not Bonsai results

Three different problems. Three research perspectives.

Evidence boundaryExternal research describes different problems and populations, not Bonsai study results. Bonsai is pre-production; improved dosing accuracy, adherence, and outcomes have not been established.

Product label accuracy

40%

12 of 30 oral cannabis oils were outside the ±15% THC label tolerance.

Study context

Products sampled from the Ontario Cannabis Store, November 2021–January 2022.

Scope and limits.

Small, nonrepresentative sample—not all cannabis. This measured label accuracy, not delivered dose. Labels mostly overstated contents; this is not evidence of widespread excess THC.

Measuring liquid medication

84.4%

Of 2,110 parents, 84.4% made at least one error across nine measured doses.

Study context

Parents of children aged 8 or younger in three US urban pediatric clinics; more than 20% deviation counted as an error.

Scope and limits.

This is the percentage of parents with at least one error—not the percentage of doses. It is not an adult cannabis study and does not establish a pediatric indication for Bonsai.

Following a prescription

About 50%

Of filled prescriptions are taken incorrectly with respect to timing, dosage, frequency, or duration.

Study context

A historical estimate cited in a CDC MMWR review published November 17, 2017.

Scope and limits.

The denominator is filled prescriptions, not people. This is a historical review estimate, not a present-day census or a cannabis-specific finding.

What this supports—and does not

Adherence is affected by cost, access, instructions, and side effects. These barriers call for support, not blame. This review did not evaluate Bonsai.

Pre-production render of the Bonsai device concept standing with an uncapped pod on a dark background
Pre-production render

Bonsai

One part of a wider care conversation.

The proposed device would work within a clinician’s plan. The companion app brings that plan together with session history and a person’s own feedback.

Physical pod reading and device activity recording are not demonstrated. The software journey uses fictional examples.

How sharing works in the software demo

Clear status

See when a record is ready to share.

In the app demo, the care team can see a record only after it uploads.

  1. Step 01
    Saved on phone

    Saved on the phone

    The session finished locally; it has not reached the server yet.

    Where it lives
    This phone
    Who can see it
    Not yet the care team
  2. Step 02
    Upload pending

    Waiting to upload

    The app will continue when connectivity is available.

    Where it lives
    On the phone until upload is confirmed
    Who can see it
    Not yet the care team
  3. Step 03
    Available for review

    Saved in the shared record

    The linked care team can review the record after upload.

    Where it lives
    Shared record
    Who can see it
    Linked care team, with permission

Saved in the shared record means the server has it. It does not mean a clinician has reviewed it yet.

Device recordPatient feedbackPermission-based review

Platform in development

More context, over time.

AI and data collection are part of the platform we’re building. We’ll share more about these capabilities as development progresses.

What does a session record tell you?

The source matters: a plan, a device event, and a patient’s feedback answer different questions.

Product + plan

What was identified or set

Product details and the clinician-set amount stay distinct from session activity.

Recorded

What a device could log

Proposed device events would describe a session, not prove chemical intake.

Reported

What a person shared

Patient feedback and reported product details remain clearly labeled.

Clear limits

Transparency is not proof of intake.

A session record cannot establish exactly what entered the body or show clinical benefit.

01

Limits set by the clinician

The plan sets the planned amount, daily count, and duration. Bonsai does not choose or change them.

02

Local patient start

The patient would start Bonsai on the device. The app demo simulates a patient start; neither supports remote dosing.

03

Sync and review

The platform shows when a record is saved on the phone, waiting to upload, or ready for team review.

04

No unsupported claims

The demo is not clinical evidence, regulatory approval, or certification. Bonsai is not available to buy or preorder.